Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Poseida Therapeutics (PSTX) just unveiled an update.
Brent Warner has announced his resignation as President of Gene Therapy at the Company, effective April 1, 2024, in order to take on a new career opportunity elsewhere. This move could signal a shift within the company and is of interest to those tracking leadership changes in the financial markets.
See more insights into PSTX stock on TipRanks’ Stock Analysis page.